Hamed, Ehab (2018) Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes. European Journal of Case Reports in Internal Medicine, 5 (10). ISSN 2284-2594
|
Text
document(22).pdf - Published Version Download (166kB) | Preview |
Abstract
We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for health. The upper limit of safe consumption is less than 400 mg per day. However, acute ingestion of high doses of caffeine may cause significant metabolic changes that can be fatal. Here the patient consumed a toxic dose of caffeine causing unpleasant and puzzling symptoms, vomiting and, following omission of his long-acting basal insulin, severe diabetic ketoacidosis. As the sports nutrition market continues to expand, providers and manufacturers have a responsibility to give clear and accurate dosing instructions as well as side effect profiles for their products, particularly for diabetic patients.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Caffeine toxicity, diabetes, diabetic ketoacidosis |
| Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Greta Di Blasio |
| Date Deposited: | 11 Jun 2019 10:45 |
| Last Modified: | 11 Jun 2019 10:45 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/18785 |
Actions (login required)
 |
View Item |
